Please watch the webcast in its entirety before proceeding to posttest.

Strategies for Optimizing the Treatment of Adult ADHD

Release Date: February 6, 2018
Expiration Date: February 6, 2019

Faculty Presenter

Ann Childress, MD
Adjunct Professor of Medicine
Department of Child and Adolescent Psychiatry
Touro University of Nevada
Center for Psychiatry and Behavioral Medicine, Inc.
Las Vegas, Nevada

Learning Objective

Upon completion of this educational activity, participants should be able to:

  • Outline a therapeutic approach for the management of ADHD in adult patients

Target Audience

This educational initiative has been designed for primary care clinicians involved in the management of adult patients with ADHD.

Directions to Learner

There are no fees for participating and receiving CME credit for this enduring activity. During the period of February 6, 2018 through February 6, 2019, participants must:

  • Read the learning objective and faculty disclosures
  • Study the educational activity
  • Complete the posttest and the evaluation form

A statement of credit will be issued upon receipt of a completed activity evaluation form and a completed posttest with a score of 100%.

Accreditation Statement

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

For questions regarding the accreditation of this activity, please contact Integrity Continuing Education, Inc. via email at This email address is being protected from spambots. You need JavaScript enabled to view it. or by phone at (888) 835-4004.


Integrity Continuing Education, Inc. designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest (COI)

Integrity Continuing Education, Inc. requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent COI they may have as related to the content of this activity. All identified COI are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The following faculty/planners reported their financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Ann Childress, MD
Consultant: Arbor, Ironshore, Neos, Neurovance, Noven, Rhodes, Shire, Sunovion, Tris
Speakers’ Bureaus: Neos, Pfizer, Shire, Tris
Research: Alcobra, Arbor, Forest, Ironshore, Lilly, Lundbeck, Otsuka, Pearson, Pfizer, Purdue, Rhodes, Shire, Sunovion, Tris

Patima Tanapat, PhD, has no real or apparent conflicts of interest to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Integrity Continuing Education, Inc. and Shire do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Integrity Continuing Education, Inc. or Shire. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.


continue to posttest

 Provided by Integrity Continuing Education, Inc.
Supported by an educational grant from Shire.